Analysis of Inventory
Paying user area
Try for free
Gilead Sciences Inc. pages available for free this week:
- Cash Flow Statement
- Common-Size Balance Sheet: Liabilities and Stockholders’ Equity
- DuPont Analysis: Disaggregation of ROE, ROA, and Net Profit Margin
- Analysis of Geographic Areas
- Price to FCFE (P/FCFE)
- Present Value of Free Cash Flow to Equity (FCFE)
- Operating Profit Margin since 2005
- Debt to Equity since 2005
- Total Asset Turnover since 2005
- Price to Sales (P/S) since 2005
The data is hidden behind: . Unhide it.
Get full access to the entire website from $10.42/mo, or
get 1-month access to Gilead Sciences Inc. for $24.99.
This is a one-time payment. There is no automatic renewal.
We accept:
Inventory Disclosure
Gilead Sciences Inc., balance sheet: inventory
US$ in millions
| Dec 31, 2024 | Dec 31, 2023 | Dec 31, 2022 | Dec 31, 2021 | Dec 31, 2020 | |||||||
|---|---|---|---|---|---|---|---|---|---|---|---|
| Raw materials | |||||||||||
| Work in process | |||||||||||
| Finished goods | |||||||||||
| Inventories | |||||||||||
| Less: Other long-term assets | |||||||||||
| Current inventories |
Based on: 10-K (reporting date: 2024-12-31), 10-K (reporting date: 2023-12-31), 10-K (reporting date: 2022-12-31), 10-K (reporting date: 2021-12-31), 10-K (reporting date: 2020-12-31).
The analysis of the financial data over the five-year period reveals several notable trends in inventory components and related asset categories.
- Raw Materials
- There is a steady upward trend in raw materials, increasing consistently from 1080 million USD in 2020 to 1295 million USD in 2024. This indicates a gradual accumulation or purchase of raw material inventory over the period.
- Work in Process
- Work in process inventory shows significant fluctuation. Beginning at 976 million USD in 2020, it declines sharply to 590 million USD in 2021, remains relatively stable at 577 million in 2022, then rises considerably to 847 million USD in both 2023 and 2024. This pattern may reflect changes in production cycles, efficiency, or demand variability.
- Finished Goods
- Finished goods inventory demonstrates a consistent increase from 958 million USD in 2020 to 1447 million USD in 2024. The steady growth suggests either increased production capacity, anticipated sales growth, or potential buildup of stock ahead of market demand.
- Total Inventories
- Total inventories exhibit a declining trend from 3014 million USD in 2020 to 2734 million in 2021, followed by a modest recovery and growth, reaching 3589 million USD by 2024. The initial dip in 2021 contrasts with a more stable and expanding inventory base in subsequent years, which may relate to supply chain adjustments or strategic inventory management.
- Other Long-term Assets
- The category labeled as other long-term assets, recorded as negative values, becomes increasingly negative over time, moving from -1331 million USD in 2020 to -1879 million USD in 2024. This deepening negative balance could reflect disposals, amortizations, impairments, or reclassifications affecting long-term asset accounts.
- Current Inventories
- Current inventories decline from 1683 million USD in 2020 to 1507 million USD in 2022, then increase to 1787 million USD in 2023 before slightly reducing to 1710 million USD in 2024. This volatility suggests adjustment in short-term stock levels potentially linked to operational demand, production scheduling, or inventory turnover strategies.
Overall, the data indicates a strategic buildup in raw materials and finished goods inventories, fluctuations in work in process suggest production variability, and a reduction followed by growth in total inventories over the period. The increasingly negative other long-term assets imply impacts on non-inventory asset categories that warrant further investigation.